DCB29 is a selective inhibitor of the BPTF bromodomain, with an IC 50 value of 13.2 μM. DCB29 can be used for the study of the BPTF-related diseases (such as bladder cancer , colorectal cancer , melanoma, leukemia, and other cancers).
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > SWI/SNF Complex
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.